<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38746213</PMID><DateRevised><Year>2024</Year><Month>05</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>medRxiv : the preprint server for health sciences</Title><ISOAbbreviation>medRxiv</ISOAbbreviation></Journal><ArticleTitle>Long-COVID improves in 50% of patients after a year in a Midwestern cohort.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2024.04.30.24306497</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1101/2024.04.30.24306497</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Many of those infected with COVID-19 experience long-term disability due to persistent symptoms known as Long-COVID, which include ongoing respiratory issues, loss of taste and smell, and impaired daily functioning.</AbstractText><AbstractText Label="RESEARCH QUESTION" NlmCategory="UNASSIGNED">This study aims to better understand the chronology of long-COVID symptoms.</AbstractText><AbstractText Label="STUDY DESIGN AND METHODS" NlmCategory="UNASSIGNED">We prospectively enrolled 403 adults from the University of Iowa long-COVID clinic (June 2020 to February 2022). Participants provided symptom data during acute illness, symptom progression, and other clinical characteristics. Patients in this registry received a survey containing questions including current symptoms and status since long-COVID diagnosis (sliding status scale, PHQ2, GAD2, MMRC). Those &gt;12 months since acute-COVID diagnosis had chart review done to track their symptomology.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Of 403 participants contacted, 129 (32%) responded. The mean age (in years) was 50.17 +/-14.28, with 31.8% male and 68.2% female. Severity of acute covid treatment was stratified by treatment in the outpatient (70.5%), inpatient (16.3%), or ICU (13.2%) settings. 51.2% reported subjective improvement (sliding scale scores of 67-100) since long-COVID onset. Ages 18-29 reported significantly higher subjective status scores. Subjective status scores were unaffected by severity. 102 respondents were &gt;12 months from their initial COVID-19 diagnosis and were tracked for longitudinal symptom persistence. All symptoms tracked had variance (mean fraction 0.58, range 0.34-0.75) in the reported symptoms at the time of long-COVID presentation when compared with patient survey report. 48 reported persistent dyspnea, 23 (48%) had resolved it at time of survey. For fatigue, 44 had persistence, 12 (27%) resolved.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">Overall, 51.2% respondents improved since their long-COVID began. Pulmonary symptoms were more persistent than neuromuscular symptoms (anosmia, dysgeusia, myalgias). Gender, time since acute COVID infection, and its severity didn't affect subjective status or symptoms. This study highlights recall bias that may be prevalent in other long-COVID research reliant on participant memory.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stalker</LastName><ForeName>Grant</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4260-7113</Identifier></Author><Author ValidYN="Y"><LastName>Tudas</LastName><ForeName>Rosarie</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-6185-6118</Identifier></Author><Author ValidYN="Y"><LastName>Garg</LastName><ForeName>Alpana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9497-0141</Identifier></Author><Author ValidYN="Y"><LastName>Graham</LastName><ForeName>Lauren</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Thurman</LastName><ForeName>Andrew L</ForeName><Initials>AL</Initials></Author><Author ValidYN="Y"><LastName>Wiblin</LastName><ForeName>R Todd</ForeName><Initials>RT</Initials></Author><Author ValidYN="Y"><LastName>Hamzeh</LastName><ForeName>Nabeel</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7296-8975</Identifier></Author><Author ValidYN="Y"><LastName>Blount</LastName><ForeName>Robert J</ForeName><Initials>RJ</Initials><Identifier Source="ORCID">0000-0001-6177-7436</Identifier></Author><Author ValidYN="Y"><LastName>Villacreses</LastName><ForeName>Raul</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-9928-0182</Identifier></Author><Author ValidYN="Y"><LastName>Zabner</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-9606-1339</Identifier></Author><Author ValidYN="Y"><LastName>Comellas</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1521-7520</Identifier></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Josalyn L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-0367-4495</Identifier></Author><Author ValidYN="Y"><LastName>Pezzulo</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-7544-5109</Identifier></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D000076942">Preprint</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>medRxiv</MedlineTA><NlmUniqueID>101767986</NlmUniqueID></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38746213</ArticleId><ArticleId IdType="pmc">PMC11092724</ArticleId><ArticleId IdType="doi">10.1101/2024.04.30.24306497</ArticleId><ArticleId IdType="pii">2024.04.30.24306497</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>